R.K. Dixon family award in Hematologic Oncology 2018/2019 Registration
Researchers interested in submitting a proposal must register by 12:00 PM (MST) on November 30, 2018 and submit their proposals by 12:00 PM (MST) January 21, 2019.
At the Alberta Cancer Foundation, we are focused on changing the lives of Albertans facing cancer. Every day, we make the most impactful improvements to cancer care in Alberta. Together, we are bringing earlier detection, improved treatments, enhanced quality of life, and prevention strategies to all Albertans so that no matter where Albertans hear the words “you have cancer”, the investments we make today will change their lives.
We are delighted to announce the first call for the R. K. Dixon Family Award in Hematologic Oncology Research. This Program has been established on behalf of Mr. Robert (Rob) Dixon through a philanthropic gift under the estate of Kathleen M. Dixon, the widow of Mr. Dixon. Faced with a diagnosis of Hodgkin’s-Lymphoma in his early 40s, Mr. Dixon turned his personal cancer journey into remarkable dedication towards advancing cancer research and education in Alberta. As the Chairman of Project Alpha and in hopes of achieving a cancer-free future, Bob led the Alberta Cancer Foundation’s first-ever capital campaign – marking the beginning of new approaches to leveraging philanthropic support for cancer research in Alberta. Recognized widely throughout Calgary for his mantra of “attitude is everything” – and fueled with positivity no matter the circumstances – he lived each day to its fullest.
The Foundation is inviting members of the Alberta cancer research and clinical community to submit specific research proposals in the area of Hematologic Oncology based at the Tom Baker Cancer Centre. We are seeking to invest in solutions that improve outcomes for Albertans facing cancer related to hematology through earlier detection, diagnosis, treatment and improved quality of life.
Individuals must be led by a Team Lead based at the Tom Baker Cancer Centre however, the team may include members from around the globe focused on making a significant impact in hematological cancer research and education. The research proposal must have a direct line of sight to patients and families and a clear and direct impact on patient outcomes.
Further information is available in the Expression of Interest FAQ
Expression of Interest Call – Cancer Early Detection 2018-2019
Individuals interested in putting forward an idea must submit an Alberta Cancer Foundation Expression of Interest Form by NOON (MST) on October 19th, 2018 and a Letter of Intent by NOON (MST) on November 2nd, 2018.
The Foundation is seeking to invest in solutions that improve outcomes for Albertans facing all cancer types through earlier detection, diagnosis and risk stratification of patients. Of particular interest are opportunities using liquid biopsies and biomarkers for the earlier detection of cancer in patients. A liquid biopsy examines a sample of blood and looks for circulating biomarkers from a tumor or for pieces of DNA from tumor cells. A liquid biopsy may be used to help find cancer at an early stage, before a patient displays any symptoms. Investments must have a direct line of sight to patients and families and a clear and direct impact on patient outcomes.
The Cancer Detection Challenge
The Alberta Cancer Foundation is partnering with two other organizations for an exciting new investment opportunity. The Cancer Detection Challenge is led by Alberta Innovates, and sponsored by Alberta Cancer Foundation and DynaLIFE Medical Labs. We are inviting members of the Alberta cancer technology, research and clinical communities to identify and support the development of technology to detect and diagnose cancer earlier, improving outcomes for Alberta patients with cancer.
